Contact Us
Biologics Contract Development Global Market Report 2025
Global Biologics Contract Development Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Biologics Contract Development Global Market Report 2025

By Source (Microbial, Mammalian, Others Sources), By Indication (Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications), By Product Service (Cell Line Development, Process Development, Others Product Services) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biologics Contract Development Market Overview

• Biologics Contract Development market size has reached to $7.75 billion in 2024

• Expected to grow to $13.08 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%

• Growth Driver: Surge In Chronic Diseases Drives Demand, Fueling Growth In The Biologics Contract Development Market

• Market Trend: Innovative Technological Integration Elevates Biologics Contract Development Market Dynamics Lonza's bYlok Platform Sets A New Standard

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biologics Contract Development Market?

biologics contract development refers to companies that provide biologics development and manufacturing services to pharmaceutical corporations on a contract basis. The biologics contract development is used to outsource the manufacturing of biologics on contracts to focus on the marketing, R&D, and branding of products.

The main source of biologics contract development are microbial, mammalian, and other sources. The microbial source of biologics contract development are used for the production of various biologics. The biologics contract development indication are oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others indications that are applied in the product service of biologics contract development such as cell line development, process development, and others product services.

Biologics Contract Development Market Size and growth rate 2025 to 2029: Graph

What Is The Biologics Contract Development Market Size 2025 And Growth Rate?

The biologics contract development market size has grown rapidly in recent years. It will grow from $7.75 billion in 2024 to $8.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to biologics market growth, rise in biopharmaceuticals, complexity of biologics, patent expirations, cost efficiency.

What Is The Biologics Contract Development Market Growth Forecast?

The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $13.08 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to digitalization and data analytics, risk management, flexibility and scalability, burgeoning investment in r&d, precision medicine and personalized therapies. Major trends in the forecast period include regenerative medicine, risk mitigation strategies, global collaborations, advanced technologies, technological integration.

The forecast of 11.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biologic innovation by inflating prices of single-use bioreactors and cell line development services developed in Ireland and Singapore, resulting in slowed drug development and higher Research and Development(R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Biologics Contract Development Market Segmented?

1) By Source: Microbial, Mammalian, Others Sources

2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others Indications

3) By Product Service: Cell Line Development, Process Development, Others Product Services

Subsegments:

1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources

2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells

3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources

What Is Driving The Biologics Contract Development Market? Surge In Chronic Diseases Drives Demand, Fueling Growth In The Biologics Contract Development Market

The rising prevalence of chronic diseases is expected to propel the biologics contract development market going forward. Chronic diseases refer to an illness that lasts for a year or longer that requires ongoing medical attention. The rise in chronic disease cases is increasing the demand for developing novel drugs, including biologics, thereby promoting the biologics contract development market. For instance, in September 2024, according to the reports published by the Office for Health Improvement & Disparities, a UK-based government, in the first half of 2023, there were 3,940 excess deaths attributed to chronic lower respiratory diseases, marking a 30% increase compared to expected rates. For the entire year, this number rose to 5,363, reflecting a 22% increase overall. Therefore, the rising prevalence of chronic diseases will drive the growth of the biologics contract development industry.

What Is Driving The Biologics Contract Development Market? Increased Investment In Biopharmaceuticals Spurs Substantial Growth In The Biologics Contract Development Market

Increasing investment in biopharmaceuticals is significantly contributing to the growth of biologics contract development market going forward. The growing demand for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, is driving companies to outsource development activities to meet market demands. For instance, in April 2024, according to the reports published by Deloitte Touche Tohmatsu Limited (DTTL), a UK-based pharmaceutical company, the total reported R&D spending in the biopharmaceutical sector increased from $139.2 billion in 2022 to $145.5 billion in 2023, marking a 4.5% increase. Therefore, increasing investment in biopharmaceuticals will drive the biologics contract development industry.

Who Are The Major Players In The Global Biologics Contract Development Market?

Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi

What Are The Key Trends Of The Global Biologics Contract Development Market? Innovative Technological Integration Elevates Biologics Contract Development Market Dynamics Lonza's bYlok Platform Sets A New Standard

Technological advancements are gaining popularity in the biologics contract development market. Major companies in the biologics contract development market are integrating advanced technologies to sustain their position in the market. For instance, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, launched bYlok technology platform to design and manufacture bispecific antibodies. It helps to solve the light-heavy chain mispairing issue with high yields, >95% accuracy, and the ability to maintain a mAb-like format. It can be accessed by pharma and biotech companies through a simple research license.

What Are The Key Trends Of The Global Biologics Contract Development Market? Integration Of Data Analytics Enhances Efficiency And Decision-Making In The Process

Major companies operating in the biologics contract development are focusing on integrating data analytics to biologics contract development process. Major companies are integrating of digital technologies and data analytics in biologics development processes for improved process monitoring, data analysis, and decision-making, enhancing efficiency and productivity. For instance, in October 2022, Evotec SE a Germany-based drug discovery and development company launched PanOmics data analysis platform PanHunter. PanHunter is Evotec's PanOmics data access and analytics technology, which has been successfully developed and deployed internally and in industry-shaping drug discovery partnerships for many years. It so facilitates, for example, patient population stratification via molecular mechanisms and the prediction of efficacy and toxicity profiles of drug candidates given suitable data inputs.

Need data on a specific region in this market?

Biologics Contract Development Market Merger And Acquisition: Recipharm Expands Capabilities With Strategic Acquisition Of Vibalogics And Arranta Bio

In February 2022, Recipharm, a Sweden-based pharmaceutical contract development and manufacturing organization, acquired Vibalogics and Arranta Bio for an undisclosed amount. This acquisition will strengthen Recipharm’s presence in advanced therapy medicinal products and enable it to expand virotherapy manufacturing capabilities in the US. Vibalogics is a Germany-based contract development and manufacturing organization. Arranta Bio is a US-based contract development and manufacturing organization.

Regional Outlook For The Global Biologics Contract Development Market

North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biologics Contract Development Market?

The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biologics Contract Development Industry?

The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biologics Contract Development Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.55 billion
Revenue Forecast In 2034 $13.08 billion
Growth Rate CAGR of 11.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Source: Microbial, Mammalian, Others Sources
2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others Indications
3) By Product Service: Cell Line Development, Process Development, Others Product Services Subsegments: 1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells
3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biologics Contract Development Market Characteristics

3. Biologics Contract Development Market Trends And Strategies

4. Biologics Contract Development Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biologics Contract Development Growth Analysis And Strategic Analysis Framework

5.1. Global Biologics Contract Development PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biologics Contract Development Market Growth Rate Analysis

5.4. Global Biologics Contract Development Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biologics Contract Development Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biologics Contract Development Total Addressable Market (TAM)

6. Biologics Contract Development Market Segmentation

6.1. Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Microbial

Mammalian

Others Soruces

6.2. Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Immunological disorders

Cardiovascular disorders

Hematological disorders

Others Indications

6.3. Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Line Development

Process Development

Others Product Services

6.4. Global Biologics Contract Development Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bacterial Sources

Yeast Sources

Fungal Sources

6.5. Global Biologics Contract Development Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chinese Hamster Ovary (CHO) Cells

Human Embryonic Kidney (HEK) Cells

Hybridoma Cells

6.6. Global Biologics Contract Development Market, Sub-Segmentation Of Other Sources, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plant-Based Systems

Insect Cell Systems

Algal Sources

7. Biologics Contract Development Market Regional And Country Analysis

7.1. Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Contract Development Market

8.1. Asia-Pacific Biologics Contract Development Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Contract Development Market

9.1. China Biologics Contract Development Market Overview

9.2. China Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Contract Development Market

10.1. India Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Contract Development Market

11.1. Japan Biologics Contract Development Market Overview

11.2. Japan Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Contract Development Market

12.1. Australia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Contract Development Market

13.1. Indonesia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Contract Development Market

14.1. South Korea Biologics Contract Development Market Overview

14.2. South Korea Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Contract Development Market

15.1. Western Europe Biologics Contract Development Market Overview

15.2. Western Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Contract Development Market

16.1. UK Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Contract Development Market

17.1. Germany Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Contract Development Market

18.1. France Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Contract Development Market

19.1. Italy Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Contract Development Market

20.1. Spain Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Contract Development Market

21.1. Eastern Europe Biologics Contract Development Market Overview

21.2. Eastern Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Contract Development Market

22.1. Russia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Contract Development Market

23.1. North America Biologics Contract Development Market Overview

23.2. North America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Contract Development Market

24.1. USA Biologics Contract Development Market Overview

24.2. USA Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Contract Development Market

25.1. Canada Biologics Contract Development Market Overview

25.2. Canada Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Contract Development Market

26.1. South America Biologics Contract Development Market Overview

26.2. South America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Contract Development Market

27.1. Brazil Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Contract Development Market

28.1. Middle East Biologics Contract Development Market Overview

28.2. Middle East Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Contract Development Market

29.1. Africa Biologics Contract Development Market Overview

29.2. Africa Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Contract Development Market Competitive Landscape And Company Profiles

30.1. Biologics Contract Development Market Competitive Landscape

30.2. Biologics Contract Development Market Company Profiles

30.2.1. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abzena Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Fujifilm Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis

30.2.4. KBI Biopharma Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AGC Biologics Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Contract Development Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. LakePharma Inc.

31.3. GenScript Biotech Corporation

31.4. Bionova Scientific Inc.

31.5. Boehringer Ingelheim GmbH

31.6. STC Biologics

31.7. Siegfried Evionnaz SA

31.8. BioAgilytix Labs Inc.

31.9. Samsung BioLogics

31.10. Forge Biologics

31.11. Lonza Group

31.12. Catalent Inc.

31.13. AbbVie Inc.

31.14. Cytovance Biologics

31.15. Emergent BioSolutions

32. Global Biologics Contract Development Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Contract Development Market

34. Recent Developments In The Biologics Contract Development Market

35. Biologics Contract Development Market High Potential Countries, Segments and Strategies

35.1 Biologics Contract Development Market In 2029 - Countries Offering Most New Opportunities

35.2 Biologics Contract Development Market In 2029 - Segments Offering Most New Opportunities

35.3 Biologics Contract Development Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biologics Contract Development Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biologics Contract Development Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biologics Contract Development Market, Sub-Segmentation Of Other Sources, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: WuXi Biologics Financial Performance
  • Table 78: Abzena Ltd. Financial Performance
  • Table 79: Fujifilm Diosynth Biotechnologies Financial Performance
  • Table 80: KBI Biopharma Financial Performance
  • Table 81: AGC Biologics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biologics Contract Development Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biologics Contract Development Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biologics Contract Development Market, Sub-Segmentation Of Other Sources, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: WuXi Biologics Financial Performance
  • Figure 78: Abzena Ltd. Financial Performance
  • Figure 79: Fujifilm Diosynth Biotechnologies Financial Performance
  • Figure 80: KBI Biopharma Financial Performance
  • Figure 81: AGC Biologics Financial Performance

Frequently Asked Questions

Biologics contract development refers to companies that provide biologics development and manufacturing services to pharmaceutical corporations on a contract basis. The biologics contract development is used to outsource the manufacturing of biologics on contracts to focus on the marketing, R&D, and branding of products. For further insights on this market, request a sample here

The market major growth driver - Surge In Chronic Diseases Drives Demand, Fueling Growth In The Biologics Contract Development Market. For further insights on this market, request a sample here

The biologics contract development market size has grown rapidly in recent years. It will grow from $7.75 billion in 2024 to $8.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to biologics market growth, rise in biopharmaceuticals, complexity of biologics, patent expirations, cost efficiency. The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to " $13.08 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to digitalization and data analytics, risk management, flexibility and scalability, burgeoning investment in r&d, precision medicine and personalized therapies. Major trends in the forecast period include regenerative medicine, risk mitigation strategies, global collaborations, advanced technologies, technological integration. For further insights on this market, request a sample here

The biologics contract developmentmarket covered in this report is segmented –
1) By Source: Microbial; Mammalian; Others Sources
2) By Indication: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Others Indications
3) By Product Service: Cell Line Development; Process Development; Others Product Services Subsegments:
1) By Microbial: Bacterial Sources; Yeast Sources; Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Hybridoma Cells
3) By Other Sources: Plant-Based Systems; Insect Cell Systems; Algal Sources For further insights on this market,
request a sample here

North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi . For further insights on this market, request a sample here.

Major trends in this market include Innovative Technological Integration Elevates Biologics Contract Development Market Dynamics Lonza's bYlok Platform Sets A New Standard. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon